Harborside Press

SHERPA: Unknown

People

  1. Saltz
    Saltz
  2. Zelenetz
    Zelenetz
  3. Yahalom
    Yahalom
  4. Abu-Rustum
    Abu-Rustum
  5. Riely
    Riely
  6. Sofocleous
    Sofocleous
  7. Shah
    Shah
  8. Pfister
    Pfister
  9. Motzer
    Motzer
  10. McCormick
    McCormick

Groups

  1. Department of Medicine (412)
  2. Solid Tumor Oncology Division (244)
  3. Surgery (172)
  4. Survivorship Research (139)
  5. Hematologic Malignancies, Division of (122)
  6. Center for Hematologic Malignancies (111)
  7. Population Sciences Research Program (102)
  8. Division of Subspecialty Medicine (77)
  9. Gastrointestinal Oncology Service (74)
  10. Radiation Oncology, Department of (72)
Search Within
Formats
  1. Journal Article (480)
  2. Guidelines (156)
  3. Review (38)
  4. Editorial (17)
  5. Conference Paper (10)
  6. Meeting Abstract (7)
  7. Correspondence (2)
Groups
  1. Department of Medicine (412)
  2. Solid Tumor Oncology Division (244)
  3. Surgery (172)
  4. Survivorship Research (139)
  5. Hematologic Malignancies, Division of (122)
  6. Center for Hematologic Malignancies (111)

More Groups

People
  1. Leonard Saltz (42)
  2. Andrew Zelenetz (35)
  3. Joachim Yahalom (31)
  4. Gregory Riely (27)
  5. Nadeem Abu-Rustum (27)
  6. Constantinos Sofocleous (22)

More People

Years
  1. 2025 (29)
  2. 2024 (38)
  3. 2023 (32)
  4. 2022 (43)
  5. 2021 (46)
  6. 2020 (35)

More Years

Publications
  1. Journal of the National Comprehensive Cancer Network (686)
  2. Journal of the Advanced Practitioner in Oncology (23)
  3. The ASCO Post (1)

Results (710)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Metastatic breast cancer, version 1.2012: Featured updates to the NCCN guidelines
    Journal Article

    Carlson, R. W.; Allred, D. C.; Anderson, B. O.; Burstein, H. J.; Edge, S. B.; Farrar, W. B.; Forero, A.; Giordano, S. H.; Goldstein, L. J.; Gradishar, W. J.; more...
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save
  • Exocrine pancreas cancer and thromboembolic events: A systematic literature review
    Journal Article

    Epstein, A. S.; O'Reilly, E. M.
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save
  • Acute myeloid leukemia
    Journal Article

    O'Donnell, M. R.; Abboud, C. N.; Altman, J.; Appelbaum, F. R.; Arber, D. A.; Attar, E.; Borate, U.; Coutre, S. E.; Damon, L. E.; Goorha, S.; more...
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save
  • Ten years of progress in head and neck cancers
    Journal Article

    Baxi, S.; Fury, M.; Ganly, I.; Rao, S.; Pfister, D. G.
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save
  • Non-Hodgkin's Lymphomas, version 3.2012: Featured updates to the NCCN guidelines
    Journal Article

    Zelenetz, A. D.; Wierda, W. G.; Abramson, J. S.; Advani, R. H.; Andreadis, C. B.; Bartlett, N.; Bellam, N.; Byrd, J. C.; Czuczman, M. S.; Fayad, L.; more...
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save
  • BRAF mutations in colorectal cancer: Clinical relevance and role in targeted therapy
    Journal Article

    Yaeger, R.; Saltz, L.
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save
  • Ovarian cancer, version 3.2012
    Journal Article

    Morgan, R. J. Jr; Alvarez, R. D.; Armstrong, D. K.; Burger, R. A.; Castells, M.; Chen, L. M.; Copeland, L.; Crispens, M. A.; Gershenson, D.; Gray, H.; more...
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save
  • Cancer survivorship: We've only just begun
    Journal Article

    McCabe, M. S.
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save
  • Palliative care: Clinical practice guidelines in oncology
    Journal Article

    Levy, M. H.; Adolph, M. D.; Back, A.; Block, S.; Codada, S. N.; Dalal, S.; Deshields, T. L.; Dexter, E.; Dy, S. M.; Knight, S. J.; more...
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save
  • A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer
    Journal Article

    Fury, M. G.; Sherman, E.; Lisa, D.; Agarwal, N.; Algazy, K.; Brockstein, B.; Langer, C.; Lim, D. ; Mehra, R.; Rajan, S. K.; more...
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save